Epidemiology of cytomegalovirus infection after pancreas transplantation

Transplantation

Volumn 92, Issue 9, 2011, Pages 1044-1050

  Parsaik, Ajay K ^a   Bhalla, Tajinder ^a   Dong, Ming ^a,b   Rostambeigi, Nassir ^a   Dierkhising, Ross A ^c   Dean, Patrick ^c   Abraham, Roshini ^c   Prieto, Mikel ^c   Kremers, Walter K ^c   Razonable, Raymund R ^c   Kudva, Yogish C ^a  

^a Divisions of Endocrinology Diabetes Metabolism and Nutrition   (United States)

^b SHANDONG UNIVERSITY   (China)

^c MAYO CLINIC   (United States)

Author keywords

Cytomegalovirus infection; Graft failure; Pancreas transplantation

Indexed keywords

ACUTE GRAFT REJECTION; ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; INFECTION PREVENTION; KIDNEY GRAFT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PANCREAS TRANSPLANTATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION; SEROPREVALENCE; VIREMIA;

ADULT; ANTIVIRAL AGENTS; COHORT STUDIES; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GRAFT REJECTION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; PANCREAS TRANSPLANTATION; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; VIREMIA;

EID: 80055000265     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31823015c1     Document Type: Article

References (28)

1. Lerner SM. Kidney and pancreas transplantation in type 1 diabetes mellitus. Mt Sinai J Med 2008; 75: 372.
2. Ricart MJ, Malaise J, Moreno A, et al. Cytomegalovirus: Occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation. Nephrol Dial Transplant 2005; 20(suppl 2): ii25.
3. Axelrod D, Leventhal JR, Gallon LG, et al. Reduction of CMV disease with steroid-free immunosuppresssion in simultaneous pancreaskidney transplant recipients. Am J Transplant 2005; 5: 1423.
4. Ciancio G, Burke GW, Mattiazzi A, et al. Cytomegalovirus prophylaxis with valganciclovir in kidney, pancreas-kidney, and pancreas transplantation. Clin Transplant 2004; 18: 402.
5. Martin-Davila P, Fortun Abete J. [Cytomegalovirus infection in kidney transplant patients: What is the best way to prevent it?]. Nefrologia 2008; 28: 253.
6. Becker BN, Becker YT, Leverson GE, et al. Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation. Am J Kidney Dis 2002; 39: 1088.
7. Klassen DK, Drachenberg CB, Papadimitriou JC, et al. CMV allograft pancreatitis: Diagnosis, treatment, and histological features. Transplantation 2000; 69: 1968.
8. Nett PC, Heisey DM, Fernandez LA, et al. Association of cytomegalovirus disease and acute rejection with graft loss in kidney transplantation. Transplantation 2004; 78: 1036.
9. Rubin RH. Impact of cytomegalovirus infection on organ transplant recipients. Rev Infect Dis 1990; 12(suppl 7): S754.
10. Backman L, Brattstrom C, Reinholt FP, et al. Development of intrapancreatic abscess -A consequence of CMV pancreatitis? Transpl Int 1991; 4: 116.
11. Humar A, Uknis M, Carlone-Jambor C, et al. Cytomegalovirus disease recurrence after ganciclovir treatment in kidney and kidney-pancreas transplant recipients. Transplantation 1999; 67: 94.
12. Schnitzler MA, Lowell JA, Hmiel SP, et al. Cytomegalovirus disease after prophylaxis with oral ganciclovir in renal transplantation: The importance of HLA-DR matching. J Am Soc Nephrol 2003; 14: 780.
13. Stratta RJ, Alloway RR, Lo A, et al. Effect of donor-recipient cytomegalovirus serologic status on outcomes in simultaneous kidney-pancreas transplant recipients. Transplant Proc 2004; 36: 1082.
14. Yakubovich N, Fung MA, Thompson DM. Three cases of cytomegalovirus infection following pancreatic islet transplantation. Transplant Proc 2007; 39: 1599.
15. Humar A, Paya C, Pescovitz MD, et al. Clinical utility of cytomegalovirus viral load testing for predicting CMV disease in D+/R+ solid organ transplant recipients. Am J Transplant 2004; 4: 644.
16. Kaufman DB, Leventhal JR, Gallon LG, et al. Risk factors and impact of cytomegalovirus disease in simultaneous pancreas-kidney transplantation. Transplantation 2001; 72: 1940.
17. Malaise J, Ricart MJ, Moreno A, et al. Cytomegalovirus infection in simultaneous pancreas-kidney transplantation. Transplant Proc 2005; 37: 2848.
18. Rayes N, Seehofer D, Kahl A, et al. Long-term outcome of cytomegalovirus infection in simultaneous pancreas-kidney transplant recipients without ganciclovir prophylaxis. Transpl Int 2007; 20: 974.
19. Fisher RA. Cytomegalovirus infection and disease in the new era of immunosuppression following solid organ transplantation. Transpl Infect Dis 2009; 11: 195.
20. Huurman VA, Kalpoe JS, van de Linde P, et al. Choice of antibody immunotherapy influences cytomegalovirus viremia in simultaneous pancreas-kidney transplant recipients. Diabetes Care 2006; 29: 842.
21. Lo A, Stratta RJ, Egidi MF, et al. Patterns of cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone with ganciclovir prophylaxis. Transpl Infect Dis 2001; 3: 8.
22. Berger N, Wirmsberger R, Kafka R, et al. Infectious complications following 72 consecutive enteric-drained pancreas transplants. Transpl Int 2006; 19: 549.
23. Paya C, Humar A, Dominguez E, et al. Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant 2004; 4: 611.
24. Akalin E, Sehgal V, Ames S, et al. Cytomegalovirus disease in high-risk transplant recipients despite ganciclovir or valganciclovir prophylaxis. Am J Transplant 2003; 3: 731.
25. Yango A, Morrissey P, Zanabli A, et al. Comparative study of prophylactic oral ganciclovir and valacyclovir in high-risk kidney transplant recipients. Nephrol Dial Transplant 2003; 18: 809.
26. Linhares MM, Gonzalez AM, Trivino T, et al. Simultaneous pancreaskidney transplantation: Infectious complications and microbiological aspects. Transplant Proc 2004; 36: 980.
27. Pavlakis M, Khwaja K, Mandelbrot D, et al. Renal allograft failure predictors after PAK transplantation: Results from the New England Collaborative Association of Pancreas Programs. Transplantation; 2010;89: 1347.
28. Razonable RR, Paya CV, Smith TF. Role of the laboratory in diagnosis and management of cytomegalovirus infection in hematopoietic stem cell and solid-organ transplant recipients. J Clin Microbiol 2002; 40: 746.